Pfizer says omicron shots substantially boosted antibodies against BA.5 subvariant in early human data
October 13, 2022 at 10:55 AM EDT
The FDA has authorized Pfizer's boosters without direct human data on how they perform against the omicron BA.5 subvariant.
